Medpace Holdings Inc (MEDP)

Fixed asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	2,108,554	2,068,966	2,028,148	1,960,912	1,899,742	1,816,339	1,717,384	1,607,723	1,488,796	1,387,029	1,289,052	1,216,138	1,145,156	1,094,017	1,028,823	955,525	926,439	896,133	881,998	891,107
Property, plant and equipment	US$ in thousands	123,615	124,058	122,394	118,600	120,589	114,764	114,817	113,755	109,849	104,719	103,538	98,529	93,153	87,703	86,195	84,504	85,017	71,472	65,954	50,015
Fixed asset turnover		17.06	16.68	16.57	16.53	15.75	15.83	14.96	14.13	13.55	13.25	12.45	12.34	12.29	12.47	11.94	11.31	10.90	12.54	13.37	17.82

December 31, 2024 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $2,108,554K ÷ $123,615K
= 17.06

The fixed asset turnover ratio for Medpace Holdings Inc has shown a generally increasing trend from March 31, 2020, to December 31, 2024. The ratio started at 17.82 on March 31, 2020, and decreased steadily to 10.90 by December 31, 2020. Subsequently, the ratio began to recover, consistently improving to reach 17.06 by December 31, 2024.

Overall, the company's efficiency in generating sales from its fixed assets has shown improvement over the period, indicating better utilization of assets to generate revenue. This upward trend suggests that the company's operational efficiency and asset management capabilities have strengthened over time. A higher fixed asset turnover ratio reflects a more efficient use of fixed assets to generate sales, which can be a positive signal for investors and creditors about the company's financial health and operational performance.